51.41
price up icon2.74%   1.37
after-market After Hours: 51.60 0.19 +0.37%
loading
Biohaven Ltd stock is traded at $51.41, with a volume of 483.62K. It is up +2.74% in the last 24 hours and up +7.94% over the past month. Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
See More
Previous Close:
$50.04
Open:
$49.81
24h Volume:
483.62K
Relative Volume:
0.51
Market Cap:
$5.05B
Revenue:
-
Net Income/Loss:
$-746.61M
P/E Ratio:
-6.8822
EPS:
-7.47
Net Cash Flow:
$-485.24M
1W Performance:
+0.90%
1M Performance:
+7.94%
6M Performance:
+26.35%
1Y Performance:
+66.81%
1-Day Range:
Value
$49.48
$51.42
1-Week Range:
Value
$48.73
$51.61
52-Week Range:
Value
$26.80
$62.21

Biohaven Ltd Stock (BHVN) Company Profile

Name
Name
Biohaven Ltd
Name
Phone
203-404-0410
Name
Address
215 CHURCH STREET, NEW HAVEN, CT
Name
Employee
239
Name
Twitter
@biohavenpharma
Name
Next Earnings Date
2022-11-07T13:30:00.000Z
Name
Latest SEC Filings
Name
BHVN's Discussions on Twitter

Biohaven Ltd Stock (BHVN) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-16-24 Initiated Jefferies Buy
Sep-04-24 Initiated Bernstein Outperform
Jul-24-24 Initiated Morgan Stanley Overweight
Feb-16-24 Initiated RBC Capital Mkts Outperform
Feb-06-24 Initiated UBS Buy
Dec-22-23 Initiated H.C. Wainwright Buy
Dec-08-23 Initiated Robert W. Baird Outperform
Jan-24-23 Initiated SVB Securities Outperform
Jan-04-23 Initiated JP Morgan Overweight
Dec-02-22 Initiated BTIG Research Buy
Oct-26-22 Upgrade Cantor Fitzgerald Neutral → Overweight
Oct-12-22 Initiated Piper Sandler Overweight
Aug-19-22 Downgrade Piper Sandler Overweight → Neutral
Aug-08-22 Downgrade Wedbush Outperform → Neutral
May-11-22 Downgrade SVB Leerink Outperform → Mkt Perform
Oct-19-21 Resumed Morgan Stanley Equal-Weight
Aug-10-21 Downgrade UBS Buy → Neutral
Aug-03-21 Reiterated Canaccord Genuity Buy
Mar-11-21 Initiated UBS Buy
Dec-15-20 Initiated H.C. Wainwright Buy
Apr-17-20 Initiated Cowen Outperform
Feb-10-20 Downgrade Oppenheimer Outperform → Perform
Feb-06-20 Initiated Mizuho Buy
Nov-22-19 Initiated Wedbush Outperform
Jun-25-19 Reiterated Canaccord Genuity Buy
May-06-19 Initiated Goldman Buy
Apr-09-19 Downgrade Morgan Stanley Overweight → Equal-Weight
Mar-04-19 Reiterated Needham Buy
Jul-03-18 Reiterated Needham Buy
Jul-02-18 Reiterated Needham Buy
Apr-05-18 Downgrade Barclays Overweight → Equal Weight
Feb-22-18 Reiterated Canaccord Genuity Buy
Dec-15-17 Initiated Canaccord Genuity Buy
Oct-03-17 Reiterated Needham Buy
View All

Biohaven Ltd Stock (BHVN) Latest News

pulisher
02:11 AM

Vanguard Group Inc's Strategic Acquisition in Biohaven Ltd - GuruFocus.com

02:11 AM
pulisher
Oct 31, 2024

(BHVN) Technical Data - Stock Traders Daily

Oct 31, 2024
pulisher
Oct 20, 2024

Cadent Capital Advisors LLC Invests $1.77 Million in Biohaven Ltd. (NYSE:BHVN) - MarketBeat

Oct 20, 2024
pulisher
Oct 20, 2024

(BHVN) Trading Advice - Stock Traders Daily

Oct 20, 2024
pulisher
Oct 16, 2024

Scholar Rock stock could benefit from Biohaven's Ph3 results, Truist raises potential rally outlook - Investing.com India

Oct 16, 2024
pulisher
Oct 15, 2024

BofA sustains Buy rating on Biohaven shares, sees SMA trial upside By Investing.com - Investing.com South Africa

Oct 15, 2024
pulisher
Oct 15, 2024

BofA sustains Buy rating on Biohaven shares, sees SMA trial upside - Investing.com UK

Oct 15, 2024
pulisher
Oct 13, 2024

Biohaven Ltd. (NYSE:BHVN) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Oct 13, 2024
pulisher
Oct 11, 2024

Biohaven: A Complicated Tale (NYSE:BHVN) - Seeking Alpha

Oct 11, 2024
pulisher
Oct 10, 2024

Biohaven Ltd. (NYSE:BHVN) Shares Acquired by AQR Capital Management LLC - MarketBeat

Oct 10, 2024
pulisher
Oct 09, 2024

(BHVN) Investment Analysis - Stock Traders Daily

Oct 09, 2024
pulisher
Oct 09, 2024

17,064 Shares in Biohaven Ltd. (NYSE:BHVN) Acquired by Squarepoint Ops LLC - MarketBeat

Oct 09, 2024
pulisher
Oct 07, 2024

Biohaven retains Outperform stock rating on clinical results By Investing.com - Investing.com South Africa

Oct 07, 2024
pulisher
Oct 07, 2024

Biohaven holds steady with $60 target on SMA trial optimism - Investing.com India

Oct 07, 2024
pulisher
Oct 07, 2024

Biohaven holds steady with $60 target on SMA trial optimism By Investing.com - Investing.com Australia

Oct 07, 2024
pulisher
Oct 07, 2024

Biohaven maintains Buy rating with $59 target amid SMA trial optimism By Investing.com - Investing.com South Africa

Oct 07, 2024
pulisher
Oct 07, 2024

Biohaven (NYSE:BHVN) Stock Price Up 4.9%Here's What Happened - MarketBeat

Oct 07, 2024
pulisher
Oct 06, 2024

Vladimir Coric Buys Handful Of Shares In Biohaven - Simply Wall St

Oct 06, 2024
pulisher
Oct 04, 2024

Biohaven Stock Soars on Drug Trial Results: Time to Jump In? - MSN

Oct 04, 2024
pulisher
Oct 04, 2024

Cantor Fitzgerald Reiterates "Overweight" Rating for Biohaven (NYSE:BHVN) - MarketBeat

Oct 04, 2024
pulisher
Oct 04, 2024

Biohaven Stock Spikes After Drug Candidate To Treat Rare Neurodegenerative Disease Shows Promise - MSN

Oct 04, 2024
pulisher
Oct 04, 2024

Analysts’ Recent Ratings Changes for Biohaven (BHVN) - Defense World

Oct 04, 2024
pulisher
Oct 03, 2024

Biohaven (NYSE:BHVN) Price Target Raised to $68.00 at JPMorgan Chase & Co. - MarketBeat

Oct 03, 2024
pulisher
Oct 03, 2024

Biohaven (NYSE:BHVN) Shares Gap Up After Insider Buying Activity - MarketBeat

Oct 03, 2024
pulisher
Oct 03, 2024

John W. Childs Purchases 21,052 Shares of Biohaven Ltd. (NYSE:BHVN) Stock - Defense World

Oct 03, 2024
pulisher
Oct 03, 2024

Bullish Biohaven Insiders Loaded Up On US$41.7m Of Stock - Yahoo Finance

Oct 03, 2024
pulisher
Oct 03, 2024

Biohaven director Childs buys shares worth nearly $1 million By Investing.com - Investing.com South Africa

Oct 03, 2024
pulisher
Oct 03, 2024

Biohaven CEO Vlad Coric acquires $999,970 in company stock By Investing.com - Investing.com Australia

Oct 03, 2024
pulisher
Oct 03, 2024

Biohaven director Childs buys shares worth nearly $1 million - Investing.com

Oct 03, 2024
pulisher
Oct 03, 2024

Biohaven CEO Vlad Coric acquires $999,970 in company stock - Investing.com India

Oct 03, 2024
pulisher
Oct 03, 2024

Marshall Wace LLP Sells 677,724 Shares of Biohaven Ltd. (NYSE:BHVN) - MarketBeat

Oct 03, 2024
pulisher
Oct 02, 2024

Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares - Lelezard.com

Oct 02, 2024
pulisher
Oct 02, 2024

Biohaven Ltd. (NYSE:BHVN) Shares Sold by Point72 Asset Management L.P. - MarketBeat

Oct 02, 2024
pulisher
Oct 01, 2024

Biohaven sets public offering price at $47.50 per share By Investing.com - Investing.com Australia

Oct 01, 2024
pulisher
Oct 01, 2024

Biohaven shares could see growth as MDD and bipolar studies advance, per TD Cowen - Investing.com India

Oct 01, 2024
pulisher
Oct 01, 2024

Biohaven (NYSE:BHVN) Sees Strong Trading Volume - MarketBeat

Oct 01, 2024
pulisher
Oct 01, 2024

Biohaven sets public offering price at $47.50 per share - Investing.com

Oct 01, 2024
pulisher
Oct 01, 2024

Biohaven down after $250 mln stock offering prices - XM

Oct 01, 2024
pulisher
Oct 01, 2024

Biohaven Announces Pricing of $250 Million Public Offering of Common Shares - Nasdaq

Oct 01, 2024
pulisher
Sep 30, 2024

Biohaven launches $250 million public stock offering By Investing.com - Investing.com Australia

Sep 30, 2024
pulisher
Sep 30, 2024

After-hours movers: IGM Biosciences, Biohaven Pharma, Acadia Realty Trust By Investing.com - Investing.com South Africa

Sep 30, 2024
pulisher
Sep 30, 2024

Biohaven launches $250 million public stock offering - Investing.com India

Sep 30, 2024
pulisher
Sep 30, 2024

After-hours movers: IGM Biosciences, Biohaven Pharma, Acadia Realty Trust - Investing.com India

Sep 30, 2024
pulisher
Sep 30, 2024

Biohaven Announces Proposed Public Offering of Common Shares - PR Newswire

Sep 30, 2024
pulisher
Sep 30, 2024

Biohaven starts phase 2 trial for new migraine treatment - Investing.com India

Sep 30, 2024
pulisher
Sep 30, 2024

Biohaven starts phase 2 trial for new migraine treatment By Investing.com - Investing.com UK

Sep 30, 2024
pulisher
Sep 30, 2024

Biohaven Initiates Pivotal Trial of Novel Investigational Drug for Treatment of Migraine - PR Newswire

Sep 30, 2024
pulisher
Sep 30, 2024

Driehaus Capital Management LLC Lowers Stake in Biohaven Ltd. (NYSE:BHVN) - MarketBeat

Sep 30, 2024
pulisher
Sep 29, 2024

Indo-Asian News Service - IANS India Pvt Ltd

Sep 29, 2024
pulisher
Sep 29, 2024

Biohaven, Tesla And Other Big Stocks Moving Higher On Monday - MSN

Sep 29, 2024
pulisher
Sep 29, 2024

97,902 Shares in Biohaven Ltd. (NYSE:BHVN) Purchased by Cubist Systematic Strategies LLC - Defense World

Sep 29, 2024

Biohaven Ltd Stock (BHVN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Cap:     |  Volume (24h):